Transcriptomic response to ex vivo IL33 stimulation of blood eosinophils from mepolizumab- or omalizumab-treated patients
RNA-Seq mRNA differential
Organism:
Homo sapiens
Publication
- Van Hulst G, Jorssen J, Jacobs N, Henket M, Louis R et al. (2022) Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma.